scholarly article | Q13442814 |
P50 | author | Sherine F Elsawa | Q59685677 |
P2093 | author name string | Esteban Celis | |
David A Rodeberg | |||
P2860 | cites work | Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes | Q24676216 |
Innate immune recognition | Q27860721 | ||
The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes | Q28139460 | ||
Tolerance, danger, and the extended family | Q29547532 | ||
Toll-like receptors and innate immunity | Q29615458 | ||
SYFPEITHI: database for MHC ligands and peptide motifs | Q29616214 | ||
Dendritic cells: specialized and regulated antigen processing machines | Q29617085 | ||
The dendritic cell system and its role in immunogenicity | Q29619870 | ||
Antigen traffic pathways in dendritic cells | Q34156635 | ||
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice | Q34420980 | ||
Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies | Q35166848 | ||
T-cell immunotherapy of cancer | Q36839453 | ||
Cytolytic T lymphocytes | Q40076423 | ||
Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes | Q40550055 | ||
T-cell adjuvants | Q40560374 | ||
Tumor antigens recognized by T lymphocytes | Q40661131 | ||
The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects | Q40661193 | ||
The biochemistry and cell biology of antigen processing and presentation | Q40898211 | ||
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors | Q41649620 | ||
Xenografts of primary human prostatic carcinoma | Q42810229 | ||
Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes | Q45771097 | ||
The Multi-epitope Approach for Immunotherapy for Cancer: Identification of Several CTL Epitopes from Various Tumor-Associated Antigens Expressed on Solid Epithelial Tumors | Q45974146 | ||
Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment | Q52010479 | ||
T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides | Q52061612 | ||
P433 | issue | 5 | |
P304 | page(s) | 563-575 | |
P577 | publication date | 2004-10-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Expert Review of Vaccines | Q15756339 |
P1476 | title | T-cell epitope peptide vaccines | |
P478 | volume | 3 |
Q34518856 | A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies |
Q34801069 | Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization. |
Q37641401 | Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumors |
Q36899098 | Experimental discovery of T-cell epitopes: combining the best of classical and contemporary approaches |
Q35982675 | Immunoglobulin Fc Fragment Tagging Allows Strong Activation of Endogenous CD4 T Cells To Reshape the Tumor Milieu and Enhance the Antitumor Effect of Lentivector Immunization |
Q42126332 | Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracis |
Q35147489 | Lentivector Prime and Vaccinia Virus Vector Boost Generate High-Quality CD8 Memory T Cells and Prevent Autochthonous Mouse Melanoma |
Q36863949 | Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunization |
Q55472927 | Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein. |
Search more.